
Rachel B. Wagman MD FACE, FACP
Diabetes, Lipid Metabolism, Osteoporosis & Bone Metabolism Medicine, Parathyroid
Clinical Development Consultant
Join to view full profile
1212 El Camino Real Suite H, #214San Bruno, CA 94066
Phone+1 650-534-4783
Dr. Wagman is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Rachel Wagman and specializes in Endocrinology with subspecialties in Osteoporosis & Bone Metabolism Medicine, and Parathyroid issues. She completed her fellowship in Endocrinology, Diabetes, and Metabolism at Stanford University after earning her medical degree and completing her residency in Internal Medicine at Thomas Jefferson University. She holds a BA in History from the University of Pennsylvania. Dr. Wagman's clinical research experience covers areas such as prostate cancer, osteoporosis, and calcium and bone metabolism. She has authored several publications, including studies on relugolix combination therapy in relation to endometriosis and uterine fibroids, denosumab, teriparatide, and romosozumab, with her work being cited multiple times in other academic publications.
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Endocrinology, Diabetes, and Metabolism, 2000 - 2002
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Internal Medicine, 1997 - 2000
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1997
University of PennsylvaniaBA, History, Distinction in History, 1989 - 1993
Certifications & Licensure
AZ State Medical License 2001 - 2027
CA State Medical License 2000 - 2027
IN State Medical License 2002 - 2027
PA State Medical License 1998 - 2026
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Publications & Presentations
PubMed
- 32 citationsTwo-year efficacy and safety of relugolix combination therapy in women with endometriosis-associated pain: SPIRIT open-label extension study.Christian M Becker, Neil P Johnson, Sawsan As-Sanie, Juan C Arjona Ferreira, Mauricio S Abrao
Human Reproduction. 2024-03-01 - 16 citationsLIBERTY randomized withdrawal study: relugolix combination therapy for heavy menstrual bleeding associated with uterine fibroids.Ayman Al-Hendy, Roberta Venturella, Juan Camilo Arjona Ferreira, Yulan Li, Graziella Soulban
American Journal of Obstetrics and Gynecology. 2023-12-01 - 3 citationsA Plain Language Summary to learn about relugolix combination therapy for the treatment of pain associated with endometriosis.Linda C Giudice, Sawsan As-Sanie, Juan C Arjona Ferreira, Christian M Becker, Mauricio S Abrao
Pain Management. 2023-11-01
Press Mentions
Single BMD and Fracture Hx May Predict Risk of Fracture in Postmenopausal WomenAugust 28th, 2017- Single BMD and Fracture Hx May Predict Risk of Fracture in Postmenopausal WomenAugust 28th, 2017
Industry Relationships
- SVP Clinical Development, Clinical Development2019 - Present
External Links
- Linked Inhttps://www.linkedin.com/in/rachel-wagman-2b3b86/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









